Menopause, lung function and obstructive lung disease outcomes: a systematic review

References

• Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404–11
   PubMed Web of Science ®Google Scholar
• Dratva J, Gómez Real F, Schindler C, et al. Is age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies. Menopause 2009;16:385–94
   PubMed Web of Science ®Google Scholar
• Sowers MR, La Pietra MT. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol Rev 1995;17:287–302
   PubMed Web of Science ®Google Scholar
• Rosano GMC, Vitale C, Marazzi G, et al. Menopause and cardiovascular disease: the evidence. Climacteric 2007;10:19–24
   PubMed Web of Science ®Google Scholar
• Lobo RA, Davis SR, De Villiers TJ, et al. Prevention of diseases after menopause. Climacteric 2014;17:540–56
   PubMed Web of Science ®Google Scholar
• Townsend EA, Miller VM, Prakash YS. Sex differences and sex steroids in lung health and disease. Endocr Rev 2012;33:1–47
   PubMed Web of Science ®Google Scholar
• Bonds RS, Midoro-Horiuti T. Estrogen effects in allergy and asthma. Curr Opin Allergy Clin Immunol 2013;13:92–9
   PubMed Web of Science ®Google Scholar
• Sin DD, Wu L, Man SFP. The relationship between reduced lung function and cardiovascular mortality. Chest 2005;127:1952–9
   PubMed Web of Science ®Google Scholar
• Bang KM, Gergen PJ, Kramer R, et al. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 1993;103:536–40
   PubMed Web of Science ®Google Scholar
• Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711–16
   PubMed Web of Science ®Google Scholar
• Tockman MS, Pearson JD, Fleg JL, et al. Rapid decline in FEV1. A new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med 1995;151:390–8
   PubMed Web of Science ®Google Scholar
• Ryan G, Knuiman MW, Divitini ML, et al. Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health 1999;53:230–4
   PubMed Web of Science ®Google Scholar
• Fireman P. Understanding asthma pathophysiology. Allergy Asthma Proc 2003;24:79–83
   PubMed Web of Science ®Google Scholar
• World Health Organization. Chronic obstructive pulmonary disease (COPD). 2016. Available from: http://www.who.int/mediacentre/factsheets/fs315/en/
   Google Scholar
• Chatila WM, Thomashow BM, Minai OA, et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:549–55
   PubMedGoogle Scholar
• Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res 2010;690:24–39
   PubMed Web of Science ®Google Scholar
• Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 2009;4:435–59
   PubMed Web of Science ®Google Scholar
• Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric 2012;15:419–29
   PubMed Web of Science ®Google Scholar
• Pucci G, Alcidi R, Tap L, et al. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res 2017;120:34–42
   PubMed Web of Science ®Google Scholar
• Pfeilschifter J, Köditz R, Pfohl M, et al. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90–119
   PubMed Web of Science ®Google Scholar
• Ballard K. Women’s use of hormone replacement therapy for disease prevention; results of a community survey. Br J Gen Pract 2002;52:835–7
   PubMed Web of Science ®Google Scholar
• Macsali F, Svanes C, Bjørge L, et al. Respiratory health in women: from menarche to menopause. Expert Rev Respir Med 2012;6:187–200
   PubMed Web of Science ®Google Scholar
• Bonner JR. The epidemiology and natural history of asthma. Clin Chest Med 1984;5:557–65
   PubMed Web of Science ®Google Scholar
• Balzano G, Fuschillo S, Melillo G, et al. Asthma and sex hormones. Allergy 2001;56:13–20
   PubMed Web of Science ®Google Scholar
• Bellia V, Augugliaro G. Asthma and menopause. Monaldi Arch Chest Dis 2016;67:125–7
   Google Scholar
• Balzano G, Fuschillo S, De Angelis E, et al. Persistent airway inflammation and high exacerbation rate in asthma that starts at menopause. Monaldi Arch Chest Dis 2007;67:135–41
   PubMedGoogle Scholar
• Zemp E, Schikowski T, Dratva J, et al. Asthma and the menopause: a systematic review and meta-analysis. Maturitas 2012;73:212–17
   PubMed Web of Science ®Google Scholar
• Troisi RJ, Speizer FE, Willett WC, et al. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am J Respir Crit Care Med 1995;152:1183–8
   PubMed Web of Science ®Google Scholar
• Lange P, Parner J, Prescott E, et al. Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population. Thorax 2001;56:613–16
   PubMed Web of Science ®Google Scholar
• Jarvis D, Leynaert B. The association of asthma, atopy and lung function with hormone replacement therapy and surgical cessation of menstruation in a population-based sample of English women. Allergy 2008;63:95–102
   PubMed Web of Science ®Google Scholar
• Amaral AFS, Strachan DP, Real FG, et al. Lower lung function associates with cessation of menstruation: UK Biobank data. Eur Respir J 2016;48:1288–97
   PubMed Web of Science ®Google Scholar
• Gómez Real F, Svanes C, Björnsson EH, et al. Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey. Thorax 2006;61:34–40
   PubMed Web of Science ®Google Scholar
• Real FG, Svanes C, Omenaas ER, et al. Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol 2008;121:72–80
   PubMed Web of Science ®Google Scholar
• Triebner K, Johannessen A, Puggini L, et al. Menopause as a predictor of new-onset asthma: a longitudinal Northern European population study. J Allergy Clin Immunol 2016;137:50–7
   PubMed Web of Science ®Google Scholar
• Songür N, Aydin ZD, Oztürk O, et al. Respiratory symptoms, pulmonary function, and reproductive history: Isparta Menopause and Health Study. J Womens Health 2010;19:1145–54
   Web of Science ®Google Scholar
• Hayatbakhsh MR, Najman JM, O’Callaghan MJ, et al. Association between smoking and respiratory function before and after menopause. Lung 2011;189:65–71
   PubMed Web of Science ®Google Scholar
• Triebner K, Matulonga B, Johannessen A, et al. Menopause is associated with accelerated lung function decline. Am J Respir Crit Care Med 2017;195:1058–65
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Aitken Z, Lawrie J, et al. Introduction to causal diagrams for confounder selection. Respirology 2014;19:303–11
   PubMed Web of Science ®Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
   PubMed Web of Science ®Google Scholar
• Romieu I, Fabre A, Fournier A, et al. Postmenopausal hormone therapy and asthma onset in the E3N cohort. Thorax 2010;65:292–7
   PubMed Web of Science ®Google Scholar
• Pata O, Atiş S, Utku Oz A, et al. The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women. Maturitas 2003;46:213–18
   PubMed Web of Science ®Google Scholar
• Cevrioglu AS, Fidan F, Unlu M, et al. The effects of hormone therapy on pulmonary function tests in postmenopausal women. Maturitas 2004;49:221–7
   PubMed Web of Science ®Google Scholar
• Carlson CL, Cushman M, Enright PL, et al. Hormone replacement therapy is associated with higher FEV1 in elderly women. Am J Respir Crit Care Med 2001;163:423–8
   PubMed Web of Science ®Google Scholar
• Hepburn MJ, Dooley DP, Morris MJ, et al. The effects of estrogen replacement therapy on airway function in postmenopausal, asthmatic women. Arch Intern Med 2001;161:2717–20
   PubMedGoogle Scholar
• Frye C, Mueller JE, Niedermeier K, et al. Maternal oral contraceptive use and atopic diseases in the offspring. Allergy 2003;58:229–32
   PubMed Web of Science ®Google Scholar
• Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28:521–74
   PubMed Web of Science ®Google Scholar
• Mohan SS, Knuiman MW, Divitini ML, et al. Higher serum testosterone and dihydrotestosterone, but not oestradiol, are independently associated with favourable indices of lung function in community-dwelling men. Clin Endocrinol 2015;83:268–76
   PubMed Web of Science ®Google Scholar
• Svartberg J, Schirmer H, Medbo A, et al. Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromso study. Eur J Epidemiol 2007;22:107–12
   PubMed Web of Science ®Google Scholar
• Carey MA, Card JW, Voltz JW, et al. It's all about sex: gender, lung development and lung disease. Trends Endocrinol Metab 2007;18:308–13
   PubMed Web of Science ®Google Scholar
• Dimitropoulou C, White E, Ownby DR, et al. Estrogen reduces carbachol-induced constriction of asthmatic airways by stimulating large-conductance voltage and calcium-dependent potassium channels. Am J Respir Cell Mol Biol 2005;32:239–47
   PubMed Web of Science ®Google Scholar
• Kouloumenta V, Hatziefthimiou A, Paraskeva E, et al. Sexual dimorphism in airway responsiveness to sex hormones in rabbits. Am J Physiol Lung Cell Mol Physiol 2007;293:L516
   PubMed Web of Science ®Google Scholar
• Pang JJ, Xu XB, Li HF, et al. Inhibition of beta-estradiol on trachea smooth muscle contraction in vitro and in vivo. Acta Pharmacol Sin 2002;23:273–7
   PubMed Web of Science ®Google Scholar
• Townsend EA, Thompson MA, Pabelick CM, et al. Rapid effects of estrogen on intracellular Ca2+ regulation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2010;298:521–30
   PubMed Web of Science ®Google Scholar
• Townsend EA, Meuchel LW, Thompson MA, et al. Estrogen increases nitric-oxide production in human bronchial epithelium. J Pharmacol Exp Ther 2011;339:815–24
   PubMed Web of Science ®Google Scholar
• Sud N, Wiseman DA, Black SM. Caveolin 1 is required for the activation of endothelial nitric oxide synthase in response to 17beta-estradiol. Mol Endocrinol 2010;24:1637–49
   PubMedGoogle Scholar
• Hamad AM, Clayton A, Islam B, et al. Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function. Am J Physiol Lung Cell Mol Physiol 2003;285:973–83
   PubMed Web of Science ®Google Scholar
• Folkerts G, Nijkamp FP. Nitric oxide in asthma therapy. Curr Pharm Des 2006;12:3221–32
   PubMed Web of Science ®Google Scholar
• Dammann CEL, Ramadurai SM, McCants DD, et al. Androgen regulation of signaling pathways in late fetal mouse lung development. Endocrinology 2000;141:2923–9
   PubMed Web of Science ®Google Scholar
• Provost PR, Simard M, Tremblay Y. A link between lung androgen metabolism and the emergence of mature epithelial type II cells. Am J Respir Crit Care Med 2004;170:296–305
   PubMed Web of Science ®Google Scholar
• Nielsen HC. Androgen receptors influence the production of pulmonary surfactant in the testicular feminization mouse fetus. J Clin Invest 1985;76:177–81
   PubMed Web of Science ®Google Scholar
• Camp PG, Coxson HO, Levy RD, et al. Sex differences in emphysema and airway disease in smokers. Chest 2009;136:1480–8
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Curtis JL, Sciurba F, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007;176:243–52
   PubMed Web of Science ®Google Scholar
• Jain R, Ray JM, Pan J, et al. Sex hormone-dependent regulation of cilia beat frequency in airway epithelium. Am J Respir Cell Mol Biol 2012;46:446–53
   PubMed Web of Science ®Google Scholar
• Card JW, Carey MA, Bradbury JA, et al. Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation. J Immunol 2006;177:621–30
   PubMed Web of Science ®Google Scholar
• Melgert BN, Postma DS, Kuipers I, et al. Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy 2005;35:1496–503
   PubMed Web of Science ®Google Scholar
• Hayashi T, Adachi Y, Hasegawa K, et al. Less sensitivity for late airway inflammation in males than females in BALB/c mice. Scand J Immunol 2003;57:562–7
   PubMed Web of Science ®Google Scholar
• Carey MA, Card JW, Voltz JW, et al. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol - Lung Cell Mol Physiol 2007;293:272–8
   PubMed Web of Science ®Google Scholar
• Gilliver SC. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 2010;120:105–15
   PubMed Web of Science ®Google Scholar
• Berger A. Th1 and Th2 responses: what are they? BMJ 2000;321:424
   PubMed Web of Science ®Google Scholar
• Soldan SS, Alvarez Retuerto AI, Sicotte NL, et al. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 2003;171:6267–74
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ. Estrogen binding by leukocytes during phagocytosis. J Exp Med 1977;145:983–98
   PubMed Web of Science ®Google Scholar
• Katayama ML, Federico MH, Brentani RR, et al. Eosinophil accumulation in rat uterus following estradiol administration is modulated by laminin and its integrin receptors. Cell Adhes Commun 1998;5:409–24
   PubMed Web of Science ®Google Scholar
• Zhao J, Jiang CQ, Lam TH, et al. Genetically predicted 17β-estradiol and systemic inflammation in women: a separate-sample Mendelian randomisation analysis in the Guangzhou Biobank Cohort Study. J Epidemiol Community Health 2014;68:780–5
   PubMed Web of Science ®Google Scholar
• Kim OY, Chae JS, Paik JK, et al. Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. Age 2012;34:415–25
   PubMed Web of Science ®Google Scholar
• Eder K, Baffy N, Falus A, et al. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 2009;58:727–36
   PubMed Web of Science ®Google Scholar
• Malutan AM, Dan M, Nicolae C, et al. Proinflammatory and anti-inflammatory cytokine changes related to menopause. Prz Menopauzalny 2014;13:162–8
   PubMedGoogle Scholar
• Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci 2012;8:1281–90
   PubMed Web of Science ®Google Scholar
• van Rooyen Y, Schutte AE, Huisman HW, et al. Inflammation as possible mediator for the relationship between lung and arterial function. Lung 2016;194:107–15
   PubMed Web of Science ®Google Scholar
• Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131–5
   PubMed Web of Science ®Google Scholar
• Aronson D, Bartha P, Zinder O, et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes 2004;28:674–9
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Boulman N, Leiba R, et al. High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol. Scand J Clin Lab Invest 2007;67:257–63
   PubMed Web of Science ®Google Scholar
• Skouby SO, Gram J, Andersen LF, et al. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations. Am J Obstet Gynecol 2002;186:969–77
   PubMed Web of Science ®Google Scholar
• Hart JE, Morse L, Tun CG, et al. Cross-sectional associations of pulmonary function with systemic inflammation and oxidative stress in individuals with chronic spinal cord injury. J Spinal Cord Med 2016;39:344–52
   PubMed Web of Science ®Google Scholar
• Fujita M, Ueki S, Ito W, et al. C-reactive protein levels in the serum of asthmatic patients. Ann Allergy Asthma Immunol 2007;99:48–53
   PubMed Web of Science ®Google Scholar
• Takemura M, Matsumoto H, Niimi A, et al. High sensitivity C-reactive protein in asthma. Eur Respir J 2006;27:908–12
   PubMed Web of Science ®Google Scholar
• Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:250–5
   PubMed Web of Science ®Google Scholar
• Aksu F, Capan N, Aksu K, et al. C-reactive protein levels are raised in stable chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis 2013;5:414–21
   PubMed Web of Science ®Google Scholar
• Davison SL, Davis SR. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 2003;88:2470–8
   PubMed Web of Science ®Google Scholar
• Tzanavari T, Giannogonas P, Karalis KP. TNF-alpha and obesity. Curr Dir Autoimmun 2010;11:145–56
   PubMedGoogle Scholar
• Nieto-Vazquez I, Fernández-Veledo S, Krämer DK, et al. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 2008;114:183–94
   PubMedGoogle Scholar
• Vural P, Canbaz M, Akgul C. Effects of menopause and postmenopausal tibolone treatment on plasma TNFalpha, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers. Pharmacol Res 2006;53:367–71
   PubMed Web of Science ®Google Scholar
• Matera MG, Calzetta L, Cazzola M. TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water. Pulm Pharmacol Ther 2010;23:121–8
   PubMed Web of Science ®Google Scholar
• Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001;34:50–9
   PubMed Web of Science ®Google Scholar
• Babu KS, Davies DE, Holgate ST. Role of tumor necrosis factor alpha in asthma. Immunol Allergy Clin North Am 2004;24:583–97
   PubMed Web of Science ®Google Scholar
• Berry M, Brightling C, Pavord I, Wardlaw A. TNF-alpha in asthma. Curr Opin Pharmacol 2007;7:279–82
   PubMed Web of Science ®Google Scholar